Yeo C J, Cameron J L, Maher M M, Sauter P K, Zahurak M L, Talamini M A, Lillemoe K D, Pitt H A
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92. doi: 10.1097/00000658-199510000-00014.
The authors hypothesized that pancreaticogastrostomy is safer than pancreaticojejunostomy after pancreaticoduodenectomy and less likely to be associated with a postoperative pancreatic fistula.
Pancreatic fistula is a leading cause of morbidity and mortality after pancreaticoduodenectomy, occurring in 10% to 20% of patients. Nonrandomized reports have suggested that pancreaticogastrostomy is less likely than pancreaticojejunostomy to be associated with postoperative complications.
Between May 1993 and January 1995, the findings for 145 patients were analyzed in this prospective trial at The Johns Hopkins Hospital. After giving their appropriate preoperative informed consent, patients were randomly assigned to pancreaticogastrostomy or pancreaticojejunostomy after completion of the pancreaticoduodenal resection. All pancreatic anastomoses were performed in two layers without pancreatic duct stents and with closed suction drainage. Pancreatic fistula was defined as drainage of greater than 50 mL of amylase-rich fluid on or after postoperative day 10.
The pancreaticogastrostomy (n = 73) and pancreaticojejunostomy (n = 72) groups were comparable with regard to multiple parameters, including demographics, medical history, preoperative laboratory values, and intraoperative factors, such as operative time, blood transfusions, pancreatic texture, length of pancreatic remnant mobilized, and pancreatic duct diameter. The overall incidence of pancreatic fistula after pancreaticoduodenectomy was 11.7% (17/145). The incidence of pancreatic fistula was similar for the pancreaticogastrostomy (12.3%) and pancreaticojejunostomy (11.1%) groups. Pancreatic fistula was associated with a significant prolongation of postoperative hospital stay (36 +/- 5 vs. 15 +/- 1 days) (p < 0.001). Factors significantly increasing the risk of pancreatic fistula by univariate logistic regression analysis included ampullary or duodenal disease, soft pancreatic texture, longer operative time, greater intraoperative red blood cell transfusions, and lower surgical volume (p < 0.05). A multivariate logistic regression analysis revealed the factors most highly associated with pancreatic fistula to be lower surgical volume and ampullary or duodenal disease in the resected specimen.
Pancreatic fistula is a common complication after pancreaticoduodenectomy, with an incidence most strongly associated with surgical volume and underlying disease. These data do not support the hypothesis that pancreaticogastrostomy is safer than pancreaticojejunostomy or is associated with a lower incidence of pancreatic fistula.
作者推测在胰十二指肠切除术后,胰胃吻合术比胰空肠吻合术更安全,且与术后胰瘘的相关性更小。
胰瘘是胰十二指肠切除术后发病和死亡的主要原因,在10%至20%的患者中发生。非随机报告表明,胰胃吻合术比胰空肠吻合术与术后并发症的相关性更小。
在1993年5月至1995年1月期间,对约翰霍普金斯医院这项前瞻性试验中的145例患者的结果进行了分析。在获得适当的术前知情同意后,患者在完成胰十二指肠切除术后被随机分配接受胰胃吻合术或胰空肠吻合术。所有胰肠吻合均分两层进行,不放置胰管支架,并采用闭式负压引流。胰瘘定义为术后第10天及以后引流出超过50 mL富含淀粉酶的液体。
胰胃吻合术组(n = 73)和胰空肠吻合术组(n = 72)在多个参数方面具有可比性,包括人口统计学、病史、术前实验室值以及术中因素,如手术时间、输血情况、胰腺质地、游离的胰腺残端长度和胰管直径。胰十二指肠切除术后胰瘘的总体发生率为11.7%(17/145)。胰胃吻合术组(12.3%)和胰空肠吻合术组(11.1%)的胰瘘发生率相似。胰瘘与术后住院时间显著延长相关(36±5天对15±1天)(p < 0.001)。单因素逻辑回归分析显示,显著增加胰瘘风险的因素包括壶腹或十二指肠疾病、胰腺质地柔软、手术时间较长、术中红细胞输血量较多以及手术量较低(p < 0.05)。多因素逻辑回归分析显示,与胰瘘相关性最高的因素是手术量较低以及切除标本中的壶腹或十二指肠疾病。
胰瘘是胰十二指肠切除术后的常见并发症,其发生率与手术量和基础疾病的相关性最强。这些数据不支持胰胃吻合术比胰空肠吻合术更安全或胰瘘发生率更低这一假设。